background image

Clinical Trials In Louisiana

Discover hundreds of clinical trials in Louisiana.
Search clinical trials in Louisiana by city, condition or phase.

e.g. Respiratory Diseases
LouisianaHealthy volunteers: No

AngelMed Guardian® System PMA Post Approval Study

Recruiting

Sponsor:

Angel Medical Systems

Location:

Mandeville, Hammond, Covington, Mesashow 10 more

Code:

NCT05412927

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

PMA P150009 AngelMed Guardian® System

MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

Recruiting

Sponsor:

Microvention-Terumo, Inc.

Location:

New Orleans, Hollywood, Orlando, Honolulushow 20 more

Code:

NCT05409989

Conditions

Intracranial Aneurysm

Eligibility Criteria

Sex: All

Age: 22 - 70+

Healthy Volunteers: Not accepted

Interventions

FRED™ X™

MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting

Sponsor:

Aegerion Pharmaceuticals, Inc.

Location:

New Orleans, New Orleans, Birmingham, Duarteshow 12 more

Code:

NCT02325674

Conditions

Generalised Lipodystrophy

Partial Lipodystrophy

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Metreleptin

Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

New Orleans, New Orleans, Phoenix, Fort Smithshow 230 more

Code:

NCT06216574

Conditions

Breast Cancer Female

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Internet-based Intervention

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Recruiting

Sponsor:

Ancora Heart, Inc.

Location:

Houma, Baton Rouge, Birmingham, Birminghamshow 99 more

Code:

NCT04331769

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)

Dilated Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AccuCinch Ventricular Restoration System

Guideline-Directed Medical Therapy

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants with MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Recruiting
PHASE3

Sponsor:

89bio, Inc.

Location:

West Monroe, Birmingham, Chandler, Flagstaffshow 80 more

Code:

NCT06318169

Conditions

Metabolic Dysfunction-associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) with Fibrosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Recruiting
PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Lafayette, Birmingham, Birmingham, Gilbertshow 137 more

Code:

NCT06221969

Conditions

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cagrilintide

Semaglutide

Tirzepatide

EMPOWER 3: Improving Palliative Care Health Literacy and Utilization

Recruiting

Sponsor:

Tulane University

Location:

New Orleans, New Orleans

Code:

NCT04733469

Conditions

Cancer

Neoplasm Malignant

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Multimedia Psychoeducational Intervention

Enhanced Usual Care

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Arvinas Androgen Receptor, Inc.

Location:

New Orleans, Duarte, Fresno, La Jollashow 19 more

Code:

NCT05067140

Conditions

Prostate Cancer Metastatic

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ARV-766 Part A&B

ARV-766 + Abiraterone Part C&D

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Shreveport, Chandler, Gilbert, Phoenixshow 135 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide